FierceBiotechOriginal article
{"a":[{"_":"Skye and Redx form new entity with $125M to advance fibrosis assets ","$":{"href":"/biotech/skye-and-redx-form-new-entity-125m-advance-fibrosis-assets","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Skye Bioscience and Redx Pharma have agreed to combine to form Fibrx Therapeutics, a public company funded with $125 million in financing to advance fibrosis disease assets.
Outcome Details
Combination agreement forming new public company
Importance:7/10
Sentiment:
0.60
M&Amergerfibrosisfinancingpublic company
Related Companies
Read the original article
Published by FierceBiotech on August 14, 2026 12:28 PM
